英格兰提议将SGLT-2抑制剂作为二型糖尿病的第一线治疗方法,旨在拯救22 000人的生命。 England proposes SGLT-2 inhibitors as first-line treatment for type 2 diabetes, aiming to save 22,000 lives.

英格兰国家健康和护理英才研究所建议对糖尿病护理进行重大改变,建议SGLT-2抑制剂作为2型糖尿病患者的第一线治疗。 England's National Institute for Health and Care Excellence (Nice) proposes significant changes in diabetes care, recommending SGLT-2 inhibitors as a first-line treatment for type 2 diabetes patients. 新的办法旨在提供个性化护理和治疗,如早些时候的减重拳,有可能预防并发症并挽救近22 000人的生命。 The new approach aims to offer personalized care and treatments like weight-loss jabs earlier, potentially preventing complications and saving nearly 22,000 lives. 准则草案在10月2日之前开放供公众协商。 The draft guidelines are open for public consultation until October 2.